Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia
Clinical trial NCT01918332 · COMPLETED
Trial details
- NCT number
- NCT01918332
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-03-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.